Xu XC - Search Results

1

Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.

Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, Feng L, Lee JJ, Cooksley CS, Parr B, Chang E, Walsh GL, Lee JS, Hong WK, Xu XC. Khuri FR, et al. Among authors: xu xc. J Clin Oncol. 2000 Aug;18(15):2798-804. doi: 10.1200/JCO.2000.18.15.2798. J Clin Oncol. 2000. PMID: 10920126

2

Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers.

Soria JC, Xu X, Liu DD, Lee JJ, Kurie J, Morice RC, Khuri F, Mao L, Hong WK, Lotan R. Soria JC, et al. J Natl Cancer Inst. 2003 Jan 15;95(2):165-8. doi: 10.1093/jnci/95.2.165. J Natl Cancer Inst. 2003. PMID: 12529350

3

Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.

Li M, Song S, Lippman SM, Zhang XK, Liu X, Lotan R, Xu XC. Li M, et al. Among authors: xu xc. Oncogene. 2002 Jan 17;21(3):411-8. doi: 10.1038/sj.onc.1205106. Oncogene. 2002. PMID: 11821953

4

Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial.

Kurie JM, Lotan R, Lee JJ, Lee JS, Morice RC, Liu DD, Xu XC, Khuri FR, Ro JY, Hittelman WN, Walsh GL, Roth JA, Minna JD, Hong WK. Kurie JM, et al. Among authors: xu xc. J Natl Cancer Inst. 2003 Feb 5;95(3):206-14. doi: 10.1093/jnci/95.3.206. J Natl Cancer Inst. 2003. PMID: 12569142 Clinical Trial.

5

Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers.

Lu C, Soria JC, Tang X, Xu XC, Wang L, Mao L, Lotan R, Kemp B, Bekele BN, Feng L, Hong WK, Khuri FR. Lu C, et al. Among authors: xu xc. J Clin Oncol. 2004 Nov 15;22(22):4575-83. doi: 10.1200/JCO.2004.01.091. J Clin Oncol. 2004. PMID: 15542809

6

Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma.

Xu XC, Lee JJ, Wu TT, Hoque A, Ajani JA, Lippman SM. Xu XC, et al. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):826-9. doi: 10.1158/1055-9965.EPI-04-0500. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824151

7

RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.

Liang ZD, Lippman SM, Wu TT, Lotan R, Xu XC. Liang ZD, et al. Among authors: xu xc. Cancer Res. 2006 Jul 15;66(14):7111-8. doi: 10.1158/0008-5472.CAN-06-0812. Cancer Res. 2006. PMID: 16849557

8

N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.

Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman SM, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu X, Lotan R, Hong WK. Kurie JM, et al. Clin Cancer Res. 2000 Aug;6(8):2973-9. Clin Cancer Res. 2000. PMID: 10955773 Clinical Trial.

9

Detection of nuclear retinoic acid receptor mRNA in histological tissue sections using nonradioactive in situ hybridization histochemistry.

Xu XC, Clifford JL, Hong WK, Lotan R. Xu XC, et al. Diagn Mol Pathol. 1994 Jun;3(2):122-31. doi: 10.1097/00019606-199406000-00009. Diagn Mol Pathol. 1994. PMID: 7520332

10

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

Xu XC, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Xu XC, et al. Cancer Res. 1995 Dec 1;55(23):5507-11. Cancer Res. 1995. PMID: 7585623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters